High Point Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
High Point Wealth Management's PFE Position: Q3 2026 in Review
High Point Wealth Management opened a new position in Pfizer (PFE) in Q3 2026: 715 shares worth $20.4K. The stake represents 0.02% of the portfolio and ranks #200 among its holdings. This is a return to the name: High Point Wealth Management previously reported a position in PFE as recently as Q1 2026.
High Point Wealth Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- High Point Wealth Management held 715 shares of Pfizer worth $20.4K as of Q3 2026.
- Pfizer was a new High Point Wealth Management position in Q3 2026.
- Pfizer made up 0.02% of High Point Wealth Management's portfolio in Q3 2026, its #200 holding.
- High Point Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on High Point Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.